The National Institute of Allergy and Infectious Diseases (NIAID) Collaborative Influenza Vaccine Innovation Centers (CIVICs) program is addressing critical gaps in the prevention and control of influenza
We interviewed the Principal Investigators responsible for leading each of the CIVICs Centers as part of a two-part interview series. Previously, we learned about the
CIVICs | Duke Vaccine Manufacturing and Toxicology Core | Principal Investigator Profile We interviewed the Principal Investigators (PIs) responsible for leading each of the CIVICs
We interviewed the Principal Investigators responsible for leading each of the CIVICs Centers as part of a two-part interview series. Previously, we learned about the
CIVICs | Principal Investigator Profile | SDMCC We interviewed the Principal Investigators (PIs) responsible for leading each of the CIVICs Centers as part of a
We interviewed the Principal Investigators responsible for leading each of the CIVICs Centers as part of a two-part interview series. Previously, we learned about the
CIVICs | Principal Investigator Profile | SEM CIVIC We interviewed the Principal Investigators (PIs) responsible for leading each of the CIVICs Centers as part of
CIVICs | SEM CIVIC | Principal Investigator Profile We interviewed the Principal Investigators (PIs) responsible for leading each of the CIVICs Centers as part of
We interviewed the Principal Investigators (PIs) responsible for leading each of the CIVICs Centers as part of a two-part interview series. Previously, we learned about
CIVICs | University of Maryland School of Medicine| Principal Investigator Profile We interviewed the Principal Investigators (PIs) responsible for leading each of the CIVICs Centers